KAIl/CD82 gene expression in benign prostatic hyperplasia and late-stage prostate cancer in Chinese

Asian Journal of Andrology

Volumn 2, Issue 3, 2000, Pages 221-224

  Hu, Wei Lie ^a   Li, Ying Qiu ^b   He, Hui Xu ^a   Li, Qing Rong ^a   Tian, Ye ^a   Lai, Ri Quan ^a   Mei, Hua ^c  

^a GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Benign prostatic hyperplasia; Immunohistochemistry; KAIl CD82; Metastasis suppressor gene expression; Prostatic neoplasms

Indexed keywords

CD82 ANTIGEN; KAI1 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; ONCOPROTEIN;

ADENOCARCINOMA; AGED; ARTICLE; CANCER STAGING; CHINA; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PROSTATE HYPERTROPHY; PROSTATE TUMOR;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CHINA; GENE EXPRESSION REGULATION; HUMANS; KANGAI-1 PROTEIN; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS;

EID: 0034279558     PISSN: 1008682X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Devita VT, Hellman S, Rosenberg SA. Cancer: principles and practice of oncology. New York; Lippincott-Raven 1997.
2. Dong JT, Lamb PW, Rinker-Schaeffer CW, Yukanovic J, Ichikawa T, Isaacs JT, et al. KAIl, a metastatic suppressor gene for prostatic cancer on human chromosome 11p11. 2. Science 1995; 268: 884-6.
3. Gaufitsch HW, Hofer E, Huber NE, Schnabl E, Baumruker T. A new superfamily of lymphoid and melanoma cell proteins with extensive homology to Schitosoma mansoni antigen Sm23. Eur J Immunol 1991; 21: 377-83.
4. Fukudome K, Furuse M, Imai T, Nishimura M, Takagi S, Himima Y, et al. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive cells. J Virol 1992; 66: 1394-401.
5. Imai T, Fukudome K, Takagi S, Nagjra M, Furuse M, Fukuhara N, et al. C33 antigen recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1-induced syncytiun formation is a member of a new family of transmembrane proteins including CD9, CD37, CD53, and CD63. J Immunol 1992; 149: 2879-86.
6. Imai T, Yoshie O. C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type 1 are both members of the transmembrane 4 superfamily and associate with each other and with CD4 or CD8 in T cells. J Immunol 1993; 151: 6470-81.
7. Dong JT, Suzuki H, Pin SS, Bova GS, Schalken JA, Isaacs WB, et al. Down-regulation of the KAIl metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation of allelic loss. Cancer Res 1996; 56: 4387-90.
8. Dong JT, Issacs WB, Barrett JC, Issace JT. Genomic organization of the human KAIl metastasis suppressor gene. Genomics 1997; 41: 25-32.
9. Ueda T, Ichikawa T, Tamaru J, Mikata A, Akakura K, Akimoto S, et al. Expression of the KAIl protein in benign prostatic hyperplasis and prostate cancer. Am J Pathol 1996; 149: 1435-40.